Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin

TI Verhoef, T Schalekamp, Ken Redekop, A Boer, AH Maitland-van der Zee

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
3 Downloads (Pure)
Original languageEnglish
Pages (from-to)375-378
Number of pages4
JournalExpert review of pharmacoeconomics & outcomes research
Volume10
Issue number4
DOIs
Publication statusPublished - 2010

Cite this